GE100 Blood Glucose Monitoring System Available

GE100 Blood Glucose Monitoring System by GE and Bionime
GE100 Blood Glucose Monitoring System by GE and Bionime

GE and Bionime announced that they have launched the GE100 Blood Glucose Monitoring System. The GE100 monitor utilizes proprietary G.O.D. (non-PQQ) technology, auto-coding to reduce the risk of false test results due to coding errors, and a patented plastic test-strip technology using a top-loading feature to reduce unnecessary sample handling. The GE100 monitor requires a minimum 1μL blood sample and provides results in five seconds. The monitor stores up to 500 test results and can calculate 1-, 7-, 14-, 30-, and 90-day averages.

For more information, call (866) 613-7085 or visit
You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs